Found 18 matching trials
Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure PHASE4 The goal of the present study is to evaluate the best regimen for inflixima...
Show More Location
The E. Wolfson.Medical Center
Learn More & Join Trial
The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease N/A In this research proposal, the investigators will focus on methods to optim...
Show More Location
Montreal General Hospital
Learn More & Join Trial
the REMONO-CD and the REMONO-UC Studies N/A Infliximab was the first-in-class anti-TNF agent approved for treating pati...
Show More Status
Enrolling By Invitation
Learn More & Join Trial
Post-Operative Crohn's Disease Outcome in Children N/A Objectives: To examine the effect of prophylaxis therapy on clinical and en...
Show More Location
Schneider Children's Hospital
Learn More & Join Trial
The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children NA The goal of this clinical trial is to investigate whether there are signifi...
Show More Location
The First People's Hospital of Yunnan
Learn More & Join Trial
Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) PHASE3 This study will be performed to compare the efficacy and safety of the clas...
Show More Location
Multiple Locations
Learn More & Join Trial
Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib PHASE4 Patients with ulcerative colitis (UC), a chronic inflammatory bowel disease...
Show More Location
Boston Medical Center
Learn More & Join Trial
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease N/A The aim of this study is to determine the impact of systemic immunosuppress...
Show More Location
Mayo Clinic Jacksonville, FL
Learn More & Join Trial
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation NA The aim of the study is to evaluate the efficacy of new immunosuppressive p...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial PHASE2 In adults hospitalized with acute severe ulcerative colitis who fail to res...
Show More Location
Asian Institute of Gastroenterology
Learn More & Join Trial